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Purpose:  The purpose of this study was to examine the relationship between self-
reported sedentary time (ST) and the cumulative risk of preserved ejection 
fraction heart failure (HFpEF) and reduced ejection fraction heart failure 
(HFrEF) using a diverse cohort of U.S. adults 45-84 years of age. 
Methods:  Using data from the Multi-Ethnic Study of Atherosclerosis (MESA), we 
identified 6,814 subjects (52.9% female). All were free of baseline 
cardiovascular disease. Cox regression was used to calculate the hazard 
ratios (HR) associated with baseline ST and risk of overall heart failure 
(HF), HFpEF, and HFrEF. Weekly self-reported ST was dichotomized 
based on the 75th percentile (1,890 min/wk).  
Results:  During an average of 11.2 years of follow-up there were 178 first incident 
HF diagnoses; 74 HFpEF, 69 HFrEF and 35 with unknown EF. Baseline 
ST >1,890 min/wk was significantly associated with an increased risk of 
HFpEF (HR [95% CI]; 1.87 [1.13 – 3.09], p= 0.01), but not HFrEF (HR 
[95% CI]; 1.30 [0.78 – 2.15], p= 0.32). The relationship with HFpEF 
remained significant in separate fully adjusted models including either 
waist circumference (HR [95% CI]; 2.16 [1.23 – 3.78], p < 0.01) or body 
mass index (HR [95% CI]; 2.17 [1.24 – 3.80], p < 0.01). Additionally, 
every 60 minute increase in weekly ST was associated with a significant 
3% increased risk of HFpEF (HR [95% CI]; 1.03 [1.01 – 1.05], p < 0.01).  
Conclusions: Sedentary time > 1,890 min/wk (~ 4.5 h/d) is a significant independent 




























 Heart failure (HF) is a chronic, progressive condition in which the myocardium is 
unable to pump enough blood through circulation to meet the body's needs (1). It is 
highly prevalent in older adults living in the United States (U.S.) (2, 3) and around the 
world (4, 5) and is accompanied by a very poor prognosis (2, 6-9). Heart failure with 
preserved ejection fraction (HFpEF) and heart failure with reduced ejection fraction 
(HFrEF) are two recognized subtypes of HF with independent pathophysiological 
pathways and risk factors (10, 11). Sedentary time (ST) has been shown to have a 
positive relationship with overall HF incidence, independent of multiple common risk 
factors, including physical activity (PA) (12).  
This chapter provides an overview of relevant background information and 
epidemiology pertaining to both HF and ST. A focused literature review on existing 
knowledge regarding the relationship between these two topics is also included. It 
concludes with the purpose and significance of this research, including the specific 
questions addressed, and a description of the project. The limitations inherent to the study 




According to 2017 estimates, the prevalence of HF among U.S. adults >20 years 
of age is currently 6.5 million (2). By 2030, this number is projected to reach 8.5 million, 
an increase of 46% from the 2012 estimates (3). Globally, based on 2014 estimates, HF 
affects at least 26 million people around the world (4). At 45 years of age, the lifetime 
risk of developing HF ranges from 20-45% (6). Presently, the HF prognosis is extremely 
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poor; approximately 50% of people receiving a HF diagnosis will die within five years 
(7, 8). In the Atherosclerosis Risk in Communities Study (13), the 30-day and 1-year case 
fatality rates after hospitalization for HF were 10.4% and 22%, respectively. One in eight 
deaths mentions HF on the death certificate and the number of deaths attributable to HF 
has remained mostly unchanged since 1995 (9). Despite the advances in health care and 
medication, the mortality and morbidity rates associated with HF remain high, while the 
quality of life remains poor.  
In the American Heart Association (AHA)/American College of Cardiology 
guidelines (14, 15), HF is defined as a complex clinical syndrome that can result from 
any structural or functional cardiac disorder that impairs the ability of the ventricle to fill 
or eject blood. As such, HF has been classified according to anatomical location (left-
sided or right-sided), etiology (systolic or diastolic), and contractile function (preserved 
or reduced ejection fraction). However, pure right-sided heart failure is uncommon; the 
most common cause of right-sided heart failure is left-sided heart failure (16-18).  
Furthermore, although congestive heart failure (CHF) has historically been used 
interchangeably with generalized HF, CHF is defined as a worsened state of HF in which 
fluid has backed up into the lungs and peripheral tissues (1). Since not all patients have 
volume overload at the time of initial or subsequent evaluation, the term heart failure is 
preferred over CHF (15).  Most recently, left ventricular ejection fraction, the percentage 
of blood that is pumped from the left ventricle, has been used to differentiate between the 
two different subtypes of left-sided HF. The demarcation points and descriptions of these 




Table 1. Heart Failure Classification by Ejection Fraction  
Classification Ejection Fraction Description 
I. Heart Failure with 
Reduced Ejection 
Fraction (HFrEF)  
≤40% Traditionally referred to as systolic HF. It is only 
in these patients that efficacious therapies have 
been demonstrated.  
II. Heart Failure with 
Preserved Ejection 
Fraction (HFpEF)  
≥50% Traditionally referred to as diastolic HF. To date, 
efficacious therapies have not been identified. 
     IIa. HFpEF,    
           borderline 
41-49% These patients fall into the borderline group. Their 
characteristics, treatment patterns, and outcomes 
appear similar to those of patients with HFpEF.  
Note. Adapted from “ACCF/AHA guideline for the management of heart failure: 
executive summary: a report of the American College of Cardiology Foundation/ 
American Heart Association Task Force on practice guidelines” by Yancy et al. 
Circulation. 2013;128(16):1810-52. 
 
 According to Yancy et al (19), HFrEF is defined as an EF ≤ 40%, HFpEF is an EF 
≥ 50%, and an EF of 41-49% is classified as borderline HFpEF. These are the cut points 
that the AHA also provides (1).  This differential diagnosis based on EF is crucial as 
previous research has demonstrated that in addition to having different risk factors and 
pathophysiology, the prognosis and response to pharmacological treatment and 
rehabilitative therapy are also different among these subgroups (10, 11, 20-22). Presently, 
therapeutic strategies that are successful in improving symptoms among those with 
HFrEF (i.e. angiotensin-converting enzyme inhibitors, angiotensin receptor antagonists, 
beta blockers) have proven ineffective on patients with HFpEF (20-22).  
Additionally, while the current prevalence of HFpEF compared to HFrEF is 
similar (47% HFpEF and 53% HFrEF),  the hospitalization rate for HFpEF is increasing; 
the average prevalence of HFpEF hospitalizations increased from 38% to 54% in a 15-
year time span (22). Furthermore, racial and gender differences in the prevalence of HF 
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subtypes exist, with black males having the highest proportion of hospitalized HFrEF 
(70%) and white females having the highest proportion of hospitalized HFpEF (59%) 
(23). 
 Several risk factors for overall HF have been identified. Common significant 
reoccurring risk factors include coronary heart disease (CHD), hypertension (HTN), 
diabetes, smoking, male gender, valvular heart disease, possessing less than a high school 
education, low PA participation, and obesity (24-26). As previously mentioned, these 
variables are not all significant predictors when HF is investigated independently by 
HFpEF and HFrEF (10, 11, 20-22).  
 
SEDENTARY TIME 
 Sedentary behavior has been defined as any waking behavior characterized by an 
energy expenditure ≤1.5 metabolic equivalents (METs), while in a sitting, reclining or 
lying posture (27). Therefore, ST is the total amount of time spent engaging in sedentary 
behaviors. This is distinctly different from physical inactivity, defined as an insufficient 
amount of PA to meet present PA recommendations (28). It is possible to meet the PA 
guidelines and still accumulate large amounts of ST. A 2013 systematic review (29) 
reported that almost 60% of older adults report sitting for more than 4 hours per day, and 
when ST was objectively measured via accelerometer, it was found that 67% of the 
population are sedentary for more than 8.5 hours in their waking day.  Another study by 
Harvey et al. (30), found that time spent sedentary ranges from 5.3–9.4 hours per waking 
day in older adults. A study utilizing a time-lapse camera and activity monitors in older 
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adults found that participants appeared to frequently have vacant (non-screen) sitting time 
(41% of total ST), however, screen ST was also prevalent (36% of total ST) (31). 
Sedentary time has been shown to have a positive, dose-response association with 
mortality from all-causes and cardiovascular disease (CVD), independent of leisure time 
PA (32, 33). Additionally, a 2015 meta-analysis (34) of 47 studies also concluded that 
self-reported prolonged ST was significantly associated with CVD incidence and CVD 
mortality (HR, 1.14 [CI, 1.00 to 1.73] and 1.15 [CI, 1.11 to 1.20], respectively) 
independent of PA. When examined as a continuous variable, each hour per day of sitting 
time was associated with 2% greater risk of CVD (HR, 1.02 [CI 1.01 to 1.03] and each 
MET-hour per week of PA with a 1% lower risk of CVD (HR, 0.990 [CI, 0.987 to 
0.992]) (35). The AHA recently released a science advisory stating that the risk of 
adverse CVD and diabetes mellitus outcomes associated with sedentary behavior must be 
quantified in order for specific sedentary behavior guidelines to be established (36).  
 
FOCUSED LITERATURE REVIEW 
The evidence suggests that a significant association exists between increased PA 
and decreased incidence of HF (37). A study by Pandey et al. (10) concluded that there is 
a strong, dose-dependent association between PA levels, body mass index (BMI), and 
risk of HF. When these investigators compared HF subtypes, higher PA levels and lower 
BMI were more consistently associated with a lower risk of HFpEF compared with 
HFrEF. Presently, there are a scarce number of studies that have examined the 
relationship between ST and HF risk. In a study by Wijndaele et al. (12), television 
viewing in hours per day was positively associated with incident HF, independent of age, 
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gender, education, smoking, alcohol, hypertension, dyslipidemia, antidepressant 
medication use, baseline diabetes status, family history of CVD, sleep duration and total 
PA. However, there is a paucity of research regarding the relationship between ST and 
the HF subtypes.  
 
PURPOSE AND SIGNIFICANCE 
In light of the poor prognosis associated with both forms of HF and the limited 
treatment options currently available for HFpEF, it is vital that more research is 
conducted to examine the individual risk factors associated with each class of HF to be 
able to target better preventive and therapeutic strategies. Therefore, the purpose of this 
study was to examine the relationship between self-reported ST and the cumulative risk 
of HFpEF and HFrEF using a diverse, population-based sample of U.S. adults. The 
specific research questions that were addressed include: 
1. Is there an association between a higher volume of total ST and the cumulative 
 risk of HF, HFrEF, or HFpEF? 
2. If a relationship does exist, does the relationship remain significant following 
adjustment for:  
a. Demographics and traditional risk factors 
b. Physical activity 







 This secondary analysis used data from the Multi-Ethnic Study of Atherosclerosis 
(MESA) (38). The MESA consists of a population-based sample of 6,814 men and non-
pregnant women aged 45-84, who were free of cardiovascular disease at baseline. The 
proportional hazards regression procedure (PROC PHREG) was utilized to calculate 
multivariable adjusted hazard ratios (HRs) to determine risk of HFpEF and HFrEF 
according to baseline, self-reported ST. Separate regression models were constructed for 
both subtypes of HF to test the relationship between several variables commonly 
associated with HFpEF and HFrEF. This study was not without limitations: 
1. The use of self-reported baseline ST is subject to recall and self-report bias. 
Additionally, ST was not objectively measured.  
2. The time to the first HF event was used to establish incident HF and EF, therefore 
subsequent HF events by the same participant or changes in EF measurement over 
time were not included in the analysis.  
3. Baseline ST and PA were examined for all participants, changes in behavior over 
the timeframe of the study were not taken into consideration for risk 
determination. 
4. Individuals without EF data at the time of the first HF event were not included in 
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Heart failure (HF) refers to a complex syndrome that encompasses many cardiac 
disorders that ultimately result in either one or both ventricles of the heart being unable to 
fill or eject blood properly (1). Cardinal symptoms of HF include dyspnea, fatigue, and 
fluid retention (2). As the heart is a very adaptive organ, the failure of the ventricles to 
work efficiently is usually the product of long term compensation of the myocardium to 
overcome a multitude of other potential underlying problems (i.e. hypertension (HTN), 
coronary artery disease (CAD), myocardial infarction, inflammation, and ischemia). 
Although HF is a chronic condition, symptoms can present acutely and progress quickly 
if untreated. Right-sided HF refers to HF in which the right chambers of the heart are 
affected. However, pure right-sided HF is uncommon; in fact, the most common cause of 
right-sided HF is left-sided HF (3-5). Furthermore, the majority of patients with left-sided 
HF have symptoms due to left ventricular (LV) myocardial dysfunction (6).  
Left ventricular ejection fraction (EF) is a measurement of the amount of blood 
that is ejected from the LV with each beat relative to the amount of blood present at the 
end of the diastole. This diagnostic tool is used to differentiate between two types of left-
sided HF: HF with reduced ejection fraction (HFrEF) and HF with preserved ejection 
fraction (HFpEF). According to the American Heart Association (AHA) (2), HFrEF is 
defined as an EF ≤ 40%, HFpEF is an EF ≥ 50%, and an EF of 41-49% is considered 
borderline HFpEF. The pathophysiological mechanisms that lead to these two subtypes of 
HF are different, multidimensional, and not fully understood at this time.  
 Traditionally, epidemiologic research involving HF was conducted investigating 
the relationship between potential risk factors and HF as one singular outcome. As 
knowledge of the different comorbidities and characteristics of patients with HFrEF and 
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HFpEF unfolded, investigators began examining the potential risk predictors of HFrEF 
and HFpEF independently (7). This led to the identification of differences in risk factors 
for each of these HF subtypes (8-13), suggesting differing etiologies.  
This chapter includes a focused history on the terminology of HFrEF and HFpEF, 
an overview of the pathophysiological mechanisms related to each of these subtypes, and 
a summary of the known risk factors independently associated with them. Additionally, 
existing knowledge about the relationship between sedentary time (ST) and HF is 
included, along with several synopses of previous research studies conducted involving 
the HF subtypes. It concludes with a summary of the literature and the explanation of the 
need for additional research.  
 
TERMINOLOGY 
Previously, the terms systolic and diastolic were primarily used to categorize HF, 
based on the phase of the cardiac cycle in which dysfunction occurred and differences in 
clinical presentation. In 2006, van Heerebeek et al. (7) investigated the distinction 
between systolic heart failure (SHF) and diastolic heart failure (DHF) by comparing LV 
myocardial structure and function using endomyocardial biopsy samples of patients with 
known SHF and DHF. Distinct cardiomyocyte abnormalities and LV remodeling were 
found to be present in each type of HF, which supported the clinical separation of HF 
patients into these SHF and DHF phenotypes. Work by Katz et al. (14) illustrated that 
patients with SHF had eccentric LV hypertrophy, evident by a low LV wall mass-volume 
ratio,  whereas patients with DHF presented with concentric LV hypertrophy or a higher 
LV wall mass-volume ratio.  
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 The terms HFrEF and HFpEF were commonly used interchangeably with SHF 
and DHF, respectively. However, because abnormalities of systolic and diastolic LV 
dysfunction were found to coexist regardless of EF, SHF and DHF are no longer the 
common vernacular (15-17). The terms HFrEF and HFpEF are currently recommended 
by the AHA and described as being a more accurate way to categorize HF patients (2). 
This is further supported by several studies that have observed differing patient 
demographics, risk factors, comorbid conditions, prognosis, and therapeutic responses 
based on EF (8-13, 18).  The Heart Failure and Echocardiography Associations of the 
European Society of Cardiology (19) also stated that structural, functional, and molecular 
biological arguments support the theory that clinical HF presents and evolves not as a 
single syndrome, but as two independent syndromes, one with reduced LVEF and the 
other with a  preserved “normal”  EF.  
 
DIAGNOSIS 
The diagnosis of HF is largely clinical and based on a thorough medical history 
and physical exam. The 2009 focused AHA guidelines (1) stated that three fundamental 
questions must be addressed in the diagnosis of HF: 
 
1) Is the LVEF preserved or reduced?  
2) Is the structure of the LV normal or abnormal?  
3) Are there other structural abnormalities such as valvular, pericardial, or right 




The diagnosis of HFpEF is often more complex, as it typically involves a more 
thorough process of eliminating other potential cardiac disorders to ensure an accurate 
diagnosis. The most recent guidelines from the AHA (20) stated that in practice, the 
diagnosis of HFpEF is based on meeting the following three requirements: 
 
1) Clinical signs or symptoms of HF 
2) Evidence of preserved or normal EF 
3) Evidence of abnormal LV diastolic dysfunction that can be determined by 
Doppler echocardiography or cardiac catheterization 
 
PATHOPHYSIOLOGY 
 As previously stated, significant evidence exists supporting the development of 
HFrEF and HFpEF as two complex syndromes. They have overlapping risk factors and 
possess similar clinical presentations, but consist of different pathologic myocardial 
remodeling pathways that result in opposing structural and functional abnormalities. 
Myocardial remodeling is used to describe a variety of changes in the biophysiology of 
the cardiomyocyte, the volume and composition of cardiomyocyte and noncardiomyocyte 
compartments, and the geometry and architecture of the LV chamber that occur in 
response to myocardial infarction, pressure or volume overload, cardiomyopathic states, 
and exposure to infectious or cardiotoxic agents (21). The complete pathological 
pathways that result in HFpEF and HFrEF are not currently completely understood, but a 






 For HFrEF, the main drivers of myocardial remodeling are a progressive loss of 
cardiomyocytes resulting from cell autophagy, apoptosis, or necrosis. This cell death is 
often the result of ischemia, infection, or toxicity that increases reactive oxygen species 
causing oxidative stress (22). These cells are then replaced with fibrous tissue. This type 
of remodeling typically results in an enlarged LV cavity that has thin, weak walls with 
patchy fibrous areas and consequently reduced pumping ability. Although the size of the 
cavity is enlarged and ventricular filling is not affected, the force of contraction the 
myocardium is able to generate is greatly diminished. This type of cardiac hypertrophy is 
typically referred to as eccentric hypertrophy.  
HFpEF 
 In contrast, concentric hypertrophy is characteristically observed in HFpEF which 
results in a thick, stiff LV wall and a reduced cavity size. While the overall EF is 
preserved, a reduction in the absolute volume of blood ejected with each beat, or stroke 
volume, is significantly reduced. While the theories behind the drivers of HFpEF are less 
understood, the consensus appears to be that it is linked to endothelial inflammation. 
Inflammation has been linked to HFpEF, but not HFrEF in several previous studies (23-
25). Chronic systemic inflammation affects not only the myocardium, but also other 
organs such as lungs, skeletal muscles, and kidneys (26). It also affects the renal 
microcirculation and the ability of the kidneys to excrete sodium, which contributes to the 
progressive fluid retention observed during transition from chronic compensated to acute 
decompensated HFpEF (26).  
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 In 2013, Paulus et al. (22) proposed a new paradigm for the development of 
HFpEF which identified a systemic proinflammatory state induced by comorbidities as 
the cause of myocardial structural and functional alterations. The new paradigm 
presumed the following sequence of events in HFpEF: 1) a high prevalence of 
comorbidities such as overweight/obesity, diabetes mellitus, chronic obstructive 
pulmonary disease, and salt-sensitive hypertension induce a systemic proinflammatory 
state; 2) a systemic proinflammatory state causes coronary microvascular endothelial 
inflammation; 3) coronary microvascular endothelial inflammation reduces nitric oxide 
bioavailability, cyclic guanosine monophosphate content, and protein kinase G (PKG) 
activity in adjacent cardiomyocytes; 4) low PKG activity favors hypertrophy 
development and increases resting tension because of hypophosphorylation of titin; and 
5) both stiff cardiomyocytes and interstitial fibrosis contribute to high diastolic LV 
stiffness and heart failure development. 
SUMMARY 
 In summary, in HFrEF, myocardial remodeling is driven by cardiomyocyte death 
due to oxidative stress originating in the cardiomyocytes as a result of ischemia, 
infection, or toxicity. In HFpEF, comorbidities contribute to a systemic inflammatory 
state, which induces oxidative stress in the coronary microvascular endothelium. The 
location of the oxidative stress dictates the type of remodeling that occurs. In HFrEF, 
eccentric hypertrophy is often observed and in HFpEF, concentric hypertrophy. 
Understanding these pathways and main drivers is critical, as it allows for a better 
understanding of potential preventative and therapeutic approaches. This is especially 




 Several prospective cohort studies have investigated the relationship between 
potential risk factors and incident HFpEF and HFrEF (8-11). A summary of these studies 
is presented in Table 1. Only risk factors that were significant in the fully-adjusted 
models are provided. The lack of consistent findings is likely a result of the differences in 





Lee et al. (8) were one of the first groups to examine antecedent clinical variables 
in participants who went on to develop HFpEF (EF > 45%) and HFrEF (EF ≤ 45%). 
Table 1. Studies Reporting Significant Risk Factors for HFpEF and HFrEF  
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Abbreviations: HFpEF= heart failure with preserved ejection fraction; HFrEF= heart failure with reduced ejection 
fraction; EF= ejection fraction; FHS= Framingham Heart Study; HTN= hypertension; CHD= coronary heart 
disease; BMI= body mass index; A-Fib= atrial fibrillation; HR= heart rate; CVD= cardiovascular disease; LVH= 
left ventricular hypertrophy; LBBB= left bundle branch block; NT-proBNP=  N-terminal pro-brain natriuretic 
peptide; UAE=  urinary albumin excretion; MI= myocardial infarction; MESA= Multi-Ethnic Study of 
Atherosclerosis; eGFR= estimated glomerular filtration rate; LV= left ventricle; PREVEND IT=  The Prevention 
of Renal and Vascular Endstage Disease Intervention Trial.  
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Using data from 314 participants in the Framingham Heart Study (FHS) who had incident 
HF occurring between 1981 and 2004, they examined the age and sex adjusted odds of 
risk factors associated with HFpEF versus HFrEF. The authors found that coronary heart 
disease was associated with significantly reduced odds of HFpEF (Odds ratio (OR), 0.38 
[CI, 0.27-0.55]). In contrast, female gender and hypertension significantly increased odds 
of HFpEF (OR, 2.55 [CI 1.77-3.68]; OR, 2.13 [CI, 1.43-3.23], respectively).  
In 2013, Ho et al. (9) examined the predictors of incident HFpEF and HFrEF also 
using data from 6,340 participants (60 ± 12 years) who participated in the FHS between 
1981 and 2008. After a mean follow-up of 7.7 years, 196 participants developed HFpEF 
(EF > 45%) and 261 developed HFrEF (EF ≤ 45%). Age, diabetes, and valvular disease 
were found to be significant predictors of both subtypes. Higher BMI, smoking, and atrial 
fibrillation were significantly associated with HFpEF, whereas male gender, cholesterol, 
heart rate, hypertension, cardiovascular disease, LV hypertrophy, and left bundle branch 
block were all associated with HFrEF.  
Brouwers et al. (10) investigated the prediction of new onset HFpEF compared 
with HFrEF using data from 8,592 participants (28-75 years) who participated in the 
Prevention of Renal and Vascular End-stage Disease (PREVEND) study. After a median 
follow-up of 11.5 years, 125 participants developed HFpEF (EF ≥ 50%) and 241 
developed HFrEF (EF ≤ 40%). The investigators found that age, female gender, history 
of atrial fibrillation, increased urinary albumin excretion, and cystatine C were all 
significantly associated with HFpEF. In contrast, male gender, smoking, increased N-
terminal pro-brain-type natriuretic peptide, and increased highly sensitive troponin T 
were associated with HFrEF.  
25 
 
Silverman et al. (11) identified various significant risk factors for HFrEF and 
HFpEF using data from 6,814 Multi-Ethnic Study of Atherosclerosis (MESA) 
participants aged 45-84 years. Proportional hazard regression models were used to 
identify the relationship between baseline characteristics and incident HFrEF and HFpEF. 
Variables that maintained significance in multivariable adjusted analysis for HFpEF and 
HFrEF are listed in adapted Table 2 and Table 3, respectively (11). Variables that did not 
make a significant contribution in the multivariable analyses are not provided.  
 
Table 2. Significant Multivariable Adjusted Risk Factors for HFpEF 
Variable Unadjusted HR (95% CI) p-value 
Multivariable 
Adjusted HR (95% CI) p-value 
Age (per SD) 2.33 (1.91–2.86) <0.001 2.27 (1.72–3.01) <0.001 
Black Race 0.69 (0.42–1.12) 0.132 0.46(0.26–0.82) 0.009 
Hypertension 3.44 (2.26–5.23) <0.001 1.81 (1.14–2.90) 0.013 
Body Mass 
Index (per SD) 1.27 (1.09–1.49) 0.002 1.35 (1.08–1.68) 0.009 
Diabetes 3.42 (2.29–5.11) <0.001 2.33 (1.47–3.71) <0.001 
LVH by ECG 5.00 (2.01–12.44) 0.001 4.33 (1.70–11.04) 0.002 
Interim MI 6.66 (3.91–11.34) <0.001 4.80 (2.67–8.62) <0.001 
Abbreviations: HFpEF= heart failure with preserved ejection fraction; HR= hazard ratio; CI= confidence 
interval; SD= standard deviation; LVH= left ventricular hypertrophy; ECG= electrocardiogram; MI= 
myocardial infarction.  
Note. Adapted from “Impact of Race, Ethnicity, and Multimodality Biomarkers on the 
Incidence of New-Onset Heart Failure With Preserved Ejection Fraction (from the Multi-











Table 3. Significant Multivariable Adjusted Risk Factors for HFrEF 
Variable Unadjusted HR (95% CI) p-value 
Multivariable Adjusted 
HR (95% CI) p-value 
Age (per SD) 1.72 (1.44–2.07) <0.001 1.30 (1.00–1.70) 0.048 
Female 0.34 (0.23–0.53) <0.001 0.34 (0.21–0.56) <0.001 
Chinese 0.08 (0.01–0.58) 0.013 0.14 (0.02–1.00) 0.05 
Heart Rate 
(per SD) 1.26 (1.04–1.53) 0.019 1.25 (1.03–1.51) 0.022 
Hypertension 3.26 (2.14–4.97) <0.001 2.04 (1.23–3.36) 0.003 
Current 
Smoking 1.68 (1.04–2.70) 0.034 2.00 (1.19–3.36) 0.009 
Diabetes 2.87 (1.88–4.38) <0.001 1.84 (1.13–3.00) 0.014 
eGFR (per 
SD) 1.60 (1.29–1.99) <0.001 1.29 (1.04–1.59) 0.019 




5.11 (3.27–7.98) <0.001 5.00 (2.70–9.25) <0.001 
LV mass 
index (per SD) 1.88 (1.59–2.22) <0.001 1.94 (1.68–2.25) <0.001 
Abbreviations: HFrEF= heart failure with reduced ejection fraction; HR= hazard ratio; LV= left 
ventricular; NT-proBNP=  N-terminal pro-brain natriuretic peptide; MI= myocardial infarction; eGFR= 
estimated glomerular filtration rate; LV= left ventricular; SD= standard deviation. 
Note. Adapted from “Impact of Race, Ethnicity, and Multimodality Biomarkers on the 
Incidence of New-Onset Heart Failure With Preserved Ejection Fraction (from the Multi-
Ethnic Study of Atherosclerosis)” by Silverman et al. The American Journal of 
Cardiology. 2016;117(9):1474-81. 
 
HF and SEDENTARY TIME 
 Sedentary behavior has been defined as any waking behavior characterized by an 
energy expenditure ≤1.5 metabolic equivalents (METs), while in a sitting, reclining or 
lying posture (27). Therefore, sedentary time (ST) is the total amount of time spent 
engaging in sedentary behaviors. This is distinctly different from physical inactivity, 
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defined as an insufficient amount of PA to meet present PA recommendations (28). It is 
possible to meet the PA guidelines and still accumulate large amounts of ST. Sedentary 
time has been shown to have a positive, dose-response association with mortality from 
all-causes and cardiovascular disease (CVD), independent of leisure time PA (29, 30). 
Additionally, a 2015 meta-analysis (31) of 47 studies also concluded that self-reported 
prolonged ST was significantly associated with CVD incidence and CVD mortality (HR, 
[95% CI]; 1.14 [ 1.00 - 1.73] and 1.15 [ 1.11 - 1.20], respectively) independent of PA. 
When examined as a continuous variable, each hour per day of sitting time was 
associated with 2% greater risk of CVD (HR [95% CI]; 1.02 [1.01 - 1.03] and each MET-
hour per week of PA with a 1% lower risk of CVD (HR, [95% CI]; 0.99 [0.99 - 0.99]) 
(32).  
 Presently, there are a scarce number of studies that have examined the 
relationship between ST and HF risk. Young et al (33) examined the relationship between 
sedentary time and incident HF in 82,694 men 45 years of age and older from the 
California Men’s Health Study. After 10 years of follow-up, 3,473 men developed HF. 
Controlling for sociodemographics, hypertension, diabetes, hyperlipidemia, body mass 
index, smoking, diet, and PA, those in the medium ST category (HR [95% CI]; 1.13 
[1.04-1.24]) and the highest ST category (HR [95% CI]; 1.34 [1.21 – 1.48]) had 
significantly increased risk of HF compared to those in the lowest ST category.  
 Additionally, in a study by Wijndaele et al. (34), the investigators examined the 
association between television viewing time and incident HF in 12,608 men and women 
from the EPIC Norfolk Study. They found that television viewing (hours/day) was 
significantly associated with incident HF, independent of age and gender (HR [95%CI]; 
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1.15 [1.05–1.25]), education, smoking, alcohol, hypertension, dyslipidaemia, 
antidepressant medication, baseline diabetes status, family history of CVD, sleep duration 
(HR [95%CI]; 1.11 [1.01–1.21]), and total PA (HR [95%CI]; 1.10 [1.01–1.20]). 
However, there is a paucity of research regarding the relationship between ST and the HF 
subtypes. 
 
RELEVANT HFpEF/HFrEF RESEARCH 
Higher levels of physical activity (PA), high cardiorespiratory fitness, lack of 
obesity and low ST have all been shown to be associated with reductions in overall HF 
risk (27, 35-44). The relationship between these variables and the risk of HFpEF and 
HFrEF subtypes is less explored. This section highlights several studies that have 
investigated some of these relationships.  
HFpEF/HFrEF AND PHYSICAL ACTIVITY 
Kraigher-Krainer et al. (45) evaluated an average of 10 years of follow-up data 
from 1,142 participants of the FHS. Participants answered questions about their PA 
participation via a questionnaire administered at baseline. Tertiles of PA were created 
based on total self-reported PA. Over the course of the study, 108 participants developed 
HFpEF and 106 HFrEF. In age- and sex-adjusted models, the middle and highest PA 
tertiles were associated with a significant 15-40% lower risk of HFrEF, and 41-66% 
lower risk of HFpEF, with a graded response across tertiles. In multivariable models, the 
association of higher PA with lower risk of HFPEF retained significance, whereas the 
significant association with HFREF was lost.  
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Pandey et al. (12) investigated the relationship between leisure time physical 
activity (LTPA) and risk of HFpEF and HFrEF using pooled data from three large, 
prospective, cohort studies; the Women’s Health Initiative, the MESA, and the 
Cardiovascular Health Study. The total sample included 51,451 participants free of 
baseline HF. Participants were stratified into four different LTPA categories: 1) No 
LTPA; 2) 1 to <500 MET-min/week; 3) 500 to 1,000 MET-min/week; 4) >1,000 MET-
min/week. After 645,515 person-years of follow-up, 3,180 HF events were observed, 
1,252 HFpEF (≥ 45% EF) and 914 HFrEF (< 45% EF). Separate multivariable adjusted 
Cox proportional hazards models were created to determine the risk of HFpEF and 
HFrEF according to baseline LTPA and BMI category. Adjusted models revealed no 
significant associations between LTPA and HFrEF at any level. In contrast, HFpEF was 
found to have a significant dose-dependent association with LTPA levels (p for trend      
< 0.01).  
HFpEF/HFrEF AND OBESITY 
Ho et al. (9) and Silverman et al. (11) both observed a significant relationship 
between BMI and HFpEF, but not HFrEF. The study by Pandey et al. (12) investigated 
the relationship between BMI and risk of overall HF and its subtypes in detail. 
Participants were placed into five separate categories based on baseline BMI: 1) 
underweight; 2) normal weight (referent group); 3) overweight; 4) obese class I; and 5) 
obese class II-III. The investigators found that participants with a higher BMI (when 
compared to desirable BMI) had a positive, graded increase in risk of HFpEF, such that 
compared to normal weight participants, overweight, obese class I, and obese class II-III 
participants had 38%, 56%, and 172% higher risk of HFpEF, respectively. A significant 
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increase in risk for HFrEF was not observed in overweight, or obese class I individuals, 
only in obese class II-III. In linear contrast analysis, a significant dose-response 
association was found between BMI and HFpEF (p < 0.01), but not HFrEF.  
 
SUMMARY 
 In summary, HFpEF and HFrEF are two subtypes of left-sided HF that have 
independent risk profiles and causal pathways. These causal pathways are typically 
driven by either several potential comorbidities that cause systemic inflammation, cardiac 
insult and cell death, or a combination of both. Depending on the original cause(s), 
differing patterns of cardiac remodeling occur, resulting in different structural and 
functional abnormalities. In the case of HFpEF, there are currently no effective 
therapeutic or pharmaceutical interventions available, therefore it is crucial to focus on 
identifying risk factors and prevention strategies. Additionally, HFpEF is more 
commonly associated with metabolic comorbidities, low levels of PA, and increased 
obesity than HFrEF. All of these are modifiable lifestyle risk factors that could be 
potential targets of prevention. As ST is also a modifiable lifestyle risk factor that has 
been shown to be associated with increased risk of HF, independent of PA, the 
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The purpose of this study was to examine the associations between sedentary time 
(ST) and the risk of overall heart failure (HF), heart failure with preserved ejection 
fraction (HFpEF) and heart failure with reduced ejection fraction (HFrEF). If a 
relationship between any of these variables was observed, the secondary aim was to see if 
the relationship was maintained after controlling for: 
1) Demographics and traditional risk factors 
2) Physical activity (PA)  
3) Adiposity measures (waist circumference [WC] and body mass index [BMI]) 
This section provides the details of the methodology that was used to address these 
research questions.  
 
DATA COLLECTION 
This study utilized data from the Multi-Ethnic Study of Atherosclerosis (MESA), an 
ongoing population-based study sponsored by the National Heart Lung and Blood 
Institute of the National Institutes of Health. Details on this study have been published 
elsewhere (1). The sample (n= 6,814) consisted of men and women (45-84 years of age) 
who were free of baseline cardiovascular disease (CVD) upon enrollment. Participants 
were recruited from six different field centers at Universities across the United States:  
1) University of California, Los Angeles, CA 
2) University of Minnesota, St. Paul, MN 
3) Northwestern University, Chicago, IL 
4) Wake Forest University, Winston-Salem, NC 
5) John Hopkins University, Baltimore, MD 
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6) Columbia University, New York, NY 
MESA's exclusion criteria were: 
1) Age younger than 45 or older than 84 years 
2) Physician-diagnosed heart attack 
3) Physician-diagnosed angina or taking nitroglycerin 
4) Physician-diagnosed stroke or transient ischemic attack  
5) Physician-diagnosed heart failure 
6) Current atrial fibrillation 
7) Having undergone procedures related to cardiovascular disease (CABG, 
angioplasty, valve replacement, pacemaker or defibrillator implantation, 
any surgery on the heart or arteries) 
8) Active treatment for cancer 
9) Pregnancy 
10) Any serious medical condition which would prevent long-term 
participation 
11) Weight >300 pounds 
12) Cognitive inability as judged by the interviewer 
13) Living in a nursing home or on the waiting list for a nursing home 
14) Plans to leave the community within five years 
15) Language barrier (speaks other than English, Spanish, Cantonese or 
Mandarin) 
16) Chest CT scan in the past year 
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The MESA utilized both physical exams and questionnaires to examine the 
characteristics of subclinical CVD and the risk factors that predict progression to 
clinically overt CVD. The first exam took place from July 2000-July 2002, and a total of 
four additional follow-up exams were completed by 2012. Participants are continuously 
contacted every 9-12 months to assess clinical morbidity and mortality data.  
The present study was reviewed and approved by the Institutional Review Board of the 
University of North Florida (Appendix A). Data from the MESA was requested and 
obtained from the National Institutes of Health/ National Heart, Lung, and Blood 
Institute: Biologic Specimen and Data Repository Information Coordinating Center (2). 
A copy of the signed research materials data agreement (RMDA) is provided in 
Appendix B.  
 
PRIMARY DEPENDENT VARIABLE 
The primary outcome was time to congestive heart failure (TTCHF), classified as 
either definite or probable. Congestive heart failure (CHF) was an adjudicated event in 
MESA, determined by a panel of physicians following review of medical records. 
Probable CHF was defined as: CHF diagnosed by physician and patient receiving 
medical treatment for CHF. Definite CHF determination required evidence of pulmonary 
edema/congestion, dilated ventricle, poor left ventricular function, or evidence of left 
ventricular diastolic dysfunction. Those with an ejection fraction (EF) ≤ 40% at time of 





PRIMARY INDEPENDENT VARIABLE 
Self-reported baseline ST based on the typical week physical activity survey (TWPAS) 
completed by all MESA participants was the primary independent variable in this study. 
The following questions from the TWPAS were used to estimate total weekly ST: 
1. “In a typical week in the past month, did you sit or recline and watch TV?”  
2. “In a typical week in the past month, did you read, knit, sew, visit, do nothing, 
non-work recreational computer?” 
Responses included yes or no, days per week (1-7days), hours per day (1-5 or 5+ hours), 
and minutes per day (5, 15, 30, or 45 minutes). Total hours per day (converted to 
minutes) and minutes per day were summed and multiplied by days per week to 
accumulate estimated minutes per week of ST.  
 
[(HR/DAY * 60 MN/HR) + MIN/DAY] * DAYS/WK = MIN/WK TOTAL ST 
  
 This variable was then used to create two separate variables used in further 
analysis: SEDDICHOT, a variable dichotomized around the 75th percentile (≤ or > 1,890 
min/wk) and SEDHOURS, a variable that represented every 1 hour interval of weekly 
ST.    
 
OTHER INDEPENDENT VARIABLES 






 Age was self-reported on the personal history form at exam one. This was 
included in the analysis as a continuous controlling variable. 
SEX 
 Sex was self-reported on the personal history form at exam one as either male or 
female. 
RACE 
 Race was self-reported on the personal history form at exam one as either 
Caucasian, Chinese, African American, or Hispanic.  
SMOKING 
 Smoking status was self-reported on the personal history form at exam one. The 
question stated, “Have you smoked cigarettes in the past 30 days?’ Responses included 
yes or no.  
HYPERTENSION 
 Self-reported based on the medical history form given at exam one. The question 
stated, “Has a doctor ever told you that you had high blood pressure or hypertension?” 
Responses included yes, no, or I don’t know. The response ‘I don’t know’ was recoded as 
a missing variable.   
DIABETES  
 Self-reported based on the medical history form given at exam one. The question 
stated, “Has a doctor ever told you that you had Diabetes (sugar in blood)?” Responses 
included yes, no, or I don’t know.  The response ‘I don’t know’ was recoded as a missing 




 Metabolic Syndrome was a calculated variable in MESA based on participants’ 
measured waist circumference, triglycerides, high density lipoprotein cholesterol, blood 
pressure, and fasting blood glucose. The MESA utilized the National Cholesterol 
Education Program Guidelines (4) to define metabolic syndrome.  
 
PHYSICAL ACTIVITY  
 An intentional physical activity variable was created in MESA that combined 
responses on the TWAPAS about time spent participating in the following activities 
(Questions 9-15): 
1) Walking for exercise, pleasure, social reasons, walking during work breaks, and 
walking the dog is classified as intentional walking.  
2) Dancing in church, ceremonies, or for pleasure.  
3) Team sports such as softball, volleyball, basketball, or soccer.  
4) Dual sports such as tennis, racketball, and paddleball.  
5) Individual activities such as golf, bowling, yoga, or t’ai chi.  
6) Moderate effort conditioning activities such as low impact aerobics, recreational 
(slow) bicycling, rowing on a rowing machine or in a lake, swimming in a pool or 
lake, or using weight lifting or conditioning machines at a health club. 
7) Heavy effort conditioning activities such as high impact aerobics (e.g., Tai-bo, 
kick boxing, judo, karate), competitive or maximum effort running, bicycling, 




BODY MASS INDEX 
 Body mass index was calculated as body weight in kilograms (kg) divided by 
height in meters squared (m2) using measurements obtained at exam one.  
WAIST CIRCUMFERENCE  
 Waist circumference was measured at exam one in centimeters (cm). 
 
STATISTICAL ANALYSIS 
Data was managed utilizing SAS 9.4 (3) where complex variable recodes, coding 
verification, and statistical analyses were performed. The means and frequency 
procedures (PROC MEANS and PROC FREQ) were used to construct a descriptive 
characteristics table for continuous and categorical variables, respectively. The univariate 
procedure (PROC UNIVARIATE) was used to determine the 75th percentile of self-
reported ST.  
Separate proportional hazards regression procedures (PROC PHREG) were 
utilized to calculate multivariable adjusted hazard ratios (HRs) to determine risk of 
overall HF, HFpEF and HFrEF according to baseline ST. Incident HF without data on 
ejection fraction were excluded from the HF subtype analysis. Five separate models were 
constructed for each of the outcome variables. Model one was unadjusted. Model two 
controlled for age, sex, race, smoking, hypertension, diabetes, and metabolic syndrome. 
Model three controlled for all variables in model two plus P A. Finally, two separate 
adiposity models were created due to the high collinearity of BMI and WC. Model four 
controlled for all variables in model three plus BMI. Model five controlled for all 
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Purpose:  The purpose of this study was to examine the relationship between self-
reported sedentary time (ST) and the cumulative risk of preserved ejection 
fraction heart failure (HFpEF) and reduced ejection fraction heart failure 
(HFrEF) using a diverse cohort of U.S. adults 45-84 years of age. 
Methods:  Using data from the Multi-Ethnic Study of Atherosclerosis (MESA), we 
identified 6,814 subjects (52.9% female). All were free of baseline 
cardiovascular disease. Cox regression was used to calculate the hazard 
ratios (HR) associated with baseline ST and risk of overall HF, HFpEF, 
and HFrEF. Weekly self-reported ST was dichotomized based on the 75th 
percentile (1,890 min/wk).  
Results:  During ~11.2 years of follow-up there were 178 first incident HF 
diagnoses; 74 HFpEF, 69 HFrEF and 35 with unknown EF. Baseline ST 
>1,890 min/wk was significantly associated with an increased risk of 
HFpEF (HR [95% CI]; 1.87 [1.13 – 3.09], p= 0.01), but not HFrEF (HR 
[95% CI]; 1.30 [0.78 – 2.15], p= 0.32). The relationship with HFpEF 
remained significant in separate fully adjusted models including either 
waist circumference (HR [95% CI]; 2.16 [1.23 – 3.78], p < 0.01) or body 
mass index (HR [95% CI]; 2.17 [1.24 – 3.80], p < 0.01). Additionally, 
every 60 minute increase in weekly ST was associated with a significant 
3% increased risk of HFpEF (HR [95% CI]; 1.03 [1.01 – 1.05], p < 0.01).  
Conclusions: Sedentary time >1,890 min/wk (~4.5 h/d) is an independent predictor of 




 According to 2017 estimates (1), the prevalence of heart failure (HF) among U.S. 
adults is currently 6.5 million. By 2030, this number is projected to reach 8.5 million, an 
increase of 46% from 2012 estimates (2). At 45 years of age, the lifetime risk of 
developing HF ranges from 20 - 45% (3). Presently, the prognosis after being diagnosed 
with HF is extremely unpromising; approximately 50% of people diagnosed will die 
within five years (4, 5, 6). In general, HF is a complex clinical syndrome that can result 
from any cardiac disorder that impairs the ability of the ventricle to function properly (7). 
The majority of HF cases affect the left ventricle of the heart, and as left-sided HF is the 
most common cause of right-sided HF, this is the focus of most HF research. Two 
subtypes of left-sided HF are currently recognized: heart failure with reduced ejection 
fraction (HFrEF) and preserved ejection fraction (HFpEF) (7, 8).  
According to Yancy et al. (8), HFrEF is defined as an EF ≤ 40%, HFpEF is an EF 
≥ 50%, and an EF of 41 - 49% is considered borderline HFpEF. This differential 
diagnosis based on EF is crucial as previous research has demonstrated that the risk 
factors, pathophysiology, prognosis and response to pharmaceutical and rehabilitative 
therapy are different among these subtypes (9-14). In HFrEF, myocardial remodeling is 
driven by cardiomyocyte death due to oxidative stress originating in the cardiomyocytes 
as a result of ischemia, infection, or toxicity, whereas in HFpEF, comorbidities contribute 
to a systemic inflammatory state, which induces oxidative stress in the coronary 
microvascular endothelium (14). Presently, therapeutic strategies that are successful in 
improving symptoms among those with HFrEF have proven ineffective on patients with 
HFpEF (9, 10). Therefore, identifying modifiable risk factors, such as sedentary time 
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(ST), which may play a role in the development of the different subtypes of HF are 
critical for developing effective prevention strategies.  
 Sedentary behavior has been defined as any waking behavior characterized by an 
energy expenditure ≤1.5 metabolic equivalents (METs), while in a sitting, reclining or 
lying posture (15). Therefore, ST is the total amount of time spent engaging in sedentary 
behaviors. This is distinctly different from physical inactivity, defined as an insufficient 
amount of physical activity (PA) to meet present PA recommendations (16). A recent 
meta-analysis of 47 studies concluded that self-reported prolonged ST was significantly 
associated with CVD incidence and CVD mortality (HR [95%CI]; 1.14 [1.00-1.73 and 
1.15 [1.11-1.20], respectively) independent of PA (17). Young et al (18) found a 
significant association between increased ST and HF risk. Additionally, a study by 
Wijndaele at al (19) observed that television viewing time, a form of ST, was positively 
associated with incident HF, independent of PA. However, little is known about the 
relationship between ST and the risk of the different subtypes of HF.  
 The purpose of this study was to examine the relationship between self-reported 
ST and the cumulative risk of HFpEF and HFrEF using a diverse, population-based 
sample of U.S. adults. Based on the inflammatory driven pathophysiology and common 
cardiometabolic risk factors associated with HFpEF, along with previous research 
demonstrating a stronger relationship with lower PA and higher BMI and HFpEF (12), 
we hypothesized that a higher volume of sedentary time would be associated with 






This study analyzed data from the MESA (20), a continuous survey sponsored by 
the National Heart Lung and Blood Institute of the National Institutes of Health. The 
MESA is a diverse, population based sample that examines the characteristics of 
subclinical cardiovascular disease and the risk factors that predict progression to 
clinically overt cardiovascular disease or progression of the subclinical disease. Details 
on this study have been published elsewhere (20). In brief, the sample (n= 6,814) 
consisted of men and women (45-84 years of age) who were free of baseline 
cardiovascular disease (CVD) upon enrollment. The MESA utilized both physical exams 
and questionnaires. The first exam took place from July 2000-July 2002, and a total of 
four additional follow-up exams were completed by 2012. Participants are continuously 
contacted every 9-12 months to assess clinical morbidity and mortality data. Data from 
the MESA was requested and obtained from the National Institutes of Health/ National 
Heart, Lung, and Blood Institute: Biologic Specimen and Data Repository Information 
Coordinating Center (21). The use of MESA data was approved by the Institutional 
Review Board of the University of North Florida. 
Dependent Variable: Heart failure, classified as either definite or probable, was an 
adjudicated event in MESA determined by a panel of physicians following review of 
patient medical records. Probable HF was defined as: HF diagnosed by physician and 
patient receiving medical treatment for HF. Definite HF determination required 
additional evidence of pulmonary edema or congestion, dilated ventricle, poor left 
ventricular function, or left ventricular diastolic dysfunction. In the present study, those 
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with an EF ≤ 40% at time of diagnosis were classified as HFrEF, and those with a 
borderline EF (41 - 49%) or an EF ≥ 50% were classified HFpEF.   
Independent Variable: Self-reported, baseline ST based on the typical week 
physical activity survey (TWPAS) completed by all MESA participants. The following 
questions from the survey were used to estimate total weekly sedentary minutes: “In a 
typical week in the past month, did you sit or recline and watch TV?” and “In a typical 
week in the past month, did you read, knit, sew, visit, do nothing, non-work recreational 
computer?” Responses included yes or no, days per week (1 - 7), hours per day (1 - 5 or 5 
+), and minutes per day (5, 15, 30, or 45). Total hours per day (converted to minutes) and 
minutes per day were summed and multiplied by days per week to accumulate an 
estimated minutes per week of ST. Total weekly ST was then used to create two ST 
variables, one dichotomized at the 75th percentile (≤ or  > 1,890 min/wk) and one that 
represented every 60 minute interval of ST.  
 Other independent measures: Age, sex, race, and smoking status were self-
reported at baseline on the personal history form. Hypertension and diabetes were also 
self-reported at baseline on the medical history form. Metabolic Syndrome was a 
calculated variable in MESA based on participants’ measured waist circumference, 
triglycerides, high density lipoprotein cholesterol, blood pressure, and fasting blood 
glucose. The MESA utilized the National Cholesterol Education Program Guidelines (21) 
to define metabolic syndrome. The intentional exercise measure using several questions 
from the TWPAS including walking, sport/dance, and conditioning, reported in MET-
minutes per day, was used to determine risk independent of PA. Body mass index (BMI) 
was calculated as body weight in kilograms (kg) divided by height in meters squared (m2) 
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using measurements obtained at exam one. Waist circumference (WC) was also measured 
at exam one in centimeters (cm). 
Statistical Analysis:  Data was managed utilizing SAS 9.4 (22) where complex 
variable recodes, coding verification, and statistical analyses were performed. The means 
and frequency procedures (PROC MEANS and PROC FREQ) were used to construct a 
descriptive characteristics table for continuous and categorical variables, respectively. 
The univariate procedure (PROC UNIVARIATE) was used to determine the 75th 
percentile of self-reported ST. Separate proportional hazards regression procedures 
(PROC PHREG) were utilized to calculate multivariable adjusted hazard ratios (HRs) to 
determine risk of overall HF, HFpEF and HFrEF according to baseline ST. Incident HF 
without data on ejection fraction were excluded from the HF subtype analysis.  
Five separate models were constructed for each of the outcome variables. Model 
one was unadjusted. Model two controlled for age, sex, race, smoking, hypertension, 
diabetes, and metabolic syndrome. Model three controlled for all variables in model two 
plus PA. Finally, two separate adiposity models were created due to the high collinearity 
of BMI and WC. Model four controlled for all variables in model three, plus BMI. Model 
five controlled for all variables in model three, plus WC. 
 
RESULTS 
Among the 178 subjects that developed HF, 143 subjects had a known EF at the 
time of HF diagnosis. Of those, 74 were categorized HFpEF and 69 HFrEF. Table 1 
contains the baseline characteristics, including demographics, race, clinical 
characteristics, and ST according to HFpEF, HFrEF, overall HF and no HF. The 
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multivariable adjusted HRs derived from the proportional hazards regression procedure 
for overall HF, HFpEF, and HFrEF are presented in Table 2. While baseline ST > 1,890 
min/wk was borderline significant, with a 38% increased risk of overall HF in the 
unadjusted model (HR [95%CI]; 1.38 [1.00-1.89], p= 0.05), this relationship was 
attenuated with further adjustments for demographics, common risk factors, PA, and 
adiposity measures, and did not remain significant. Baseline ST was not significantly 



















Table 1. Baseline Characteristics 
Total n = 6,814 HFrEF  (n = 69) 
HFpEF  
(n = 74) 
Overall HF 
(n = 178) 
No HF  
(n = 6,636) 
 Demographics 
    Age (years)  68 (± 9.0) 69 (± 8.6) 69 (± 8.7) 62 (± 10.2) 
    Male 49 (71.0%) 38 (51.4%) 106 (59.6%) 3,107 (46.8%) 
 Race/Ethnicity 
    White 28 (40.6%) 32 (43.2%) 69 (38.8%) 2,553 (38.5%) 
    African American 28 (40.6%) 18 (24.3%) 61 (34.3%) 1,831 (27.6%) 
    Hispanic 13 (18.8%) 15 (20.3%) 38 (21.4%) 1,458 (22.0%) 
    Chinese 0 (0.0%) 9 (12.2%) 10 (5.6%) 794 (12.0%) 
 Clinical Characteristics 
    Heart Rate (bpm) 64 (± 11.5) 64 (± 9.8) 65 (± 11.1) 63 (± 9.6) 
    BMI (kg/m2) 29.2 (± 5.1) 30.3 (± 6.0) 30.2 (± 6.2) 28.3 (± 5.4) 
    WC (cm)  104.1 (± 18) 105.6 (± 15.1) 105.7 (± 17.3)  98.0 (± 14.3)  
    Hypertension  51 (73.9%) 58 (78.4%) 135 (75.8%) 2,923 (44.1%) 
    Metabolic Syndrome 33 (47.8%) 44 (59.5%) 96 (53.9%) 2,353 (35.6%) 
    Diabetes 19 (27.9%) 25 (33.8%) 56 (31.6%) 717 (10.8%) 
    Current Smoking 15 (21.7%) 8 (10.8%) 28 (15.7%) 860 (13.0%) 
Sedentary Time 
    Average (min/week) 1,687.3 1,595.3 1,648.0 1,427.4 
    ≤ 1,890 min/week 45 (66.2%) 50 (67.6%) 119 (67.2%) 5,001 (75.6%) 
    > 1,890 min/week 23 (33.8%) 24 (32.4%) 58 (32.8%) 1,617 (24.4%) 
Values are expressed in mean (SD) for continuous variables and n (%) for categorical variables.  
Abbreviations: HF = heart failure; HFpEF = heart failure with preserved ejection fraction; HFrEF 
= heart failure with reduced ejection fraction; BMI = body mass index (kg/m2); WC = waist 







Table 2. Hazard Ratios Associated with Sedentary Time (ST) >1,890 min/wk and Risk of Incident 
Heart Failure 
  Overall HF HFpEF HFrEF 
HR [95% CI] P-value HR [95% CI] P-value HR [95% CI] P-value 
Model 1 1.38 [1.00-1.89] 0.05 1.87 [1.13-3.09] 0.01 1.30 [0.78-2.15] 0.32 
Model 2 1.25 [0.89-1.74] 0.20 1.90 [1.09-3.30] 0.02 1.15 [0.66-2.00] 0.62 
Model 3 1.25 [0.90-1.75] 0.19 1.92 [1.10-3.36] 0.02 1.15 [0.66-2.00] 0.63 
Model 4 1.25 [0.89-1.75] 0.20 2.16 [1.23-3.78] < 0.01 1.20 [0.64-2.23] 0.57 
Model 5 1.23 [0.88-1.72] 0.24 2.17 [1.24-3.80] < 0.01 1.18 [0.65-2.15] 0.58 
Per 60 min ST 1.01 [1.00-1.02] 0.28 1.03 [1.01-1.05] < 0.01 1.01 [0.99-1.02] 0.57 
Model 1: unadjusted 
Model 2: adjusted for age, sex, race, smoking, hypertension, diabetes, and metabolic syndrome 
Model 3: model 2 additionally adjusted for physical activity (METS)  
Model 4: model 3 additionally adjusted for waist circumference (cm)  
Model 5: model 3 additionally adjusted for body mass index (kg/m2) 
Per 60 min ST: adjusted for all variables in model 4 
Abbreviations: min/wk= minutes per week; HFpEF= heart failure with preserved ejection fraction; 
HFrEF= heart failure with reduced ejection fraction; HR= hazard ratio; CI= confidence interval. 
 
In the unadjusted model, baseline ST > 1,890 min/wk was significantly associated 
with an 87% increased risk of HFpEF (HR [95% CI]; 1.87 [1.13-3.09]) when compared 
to those with ST ≤ 1,890 min/wk. The relationship remained significant following 
adjustment for age, sex, race, smoking, hypertension, diabetes, and metabolic syndrome 
(HR [95% CI]; 1.90 [1.09-3.30]). The addition of PA (HR [95% CI]; 1.92 [1.10-3.36]), 
and adiposity measures WC (HR [95% CI]; 2.16 [1.23-3.78]) and BMI (HR [95% CI]; 
2.17 [1.24-3.80]) did not attenuate significance. Similarly, when ST was evaluated for 
every 60 minute increase, a significant relationship was only observed with HFpEF. 
Every 1 hour increase in weekly ST was associated with a 3% increased risk of HFpEF 
(HR [95% CI]; 1.03 [1.01-1.05]), independent of all variables in model 4. A 1% 
increased risk was observed for overall HF that was borderline significant (p= 0.06) in 
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the crude model, however significance was lost following further adjustment. No such 
relationship was observed with HFrEF. 
 
DISCUSSION 
In the current study, a statistically significant relationship between a higher 
volume of ST and risk of HFpEF was observed. Additionally, this relationship remained 
significant when demographics, several traditional risk factors, intentional exercise, and 
adiposity measures were added to the model. Furthermore, for every hour of increased 
weekly ST, a significant 3% increased risk of HFpEF was observed. Borderline 
significance in the crude model was observed for overall HF, however this was attenuated 
following further adjustment. No association between ST and risk of HFrEF was detected 
in any of the models.  
 Several studies have found an association between higher volumes of ST and 
increased risk of overall HF (18, 19), however the relationship between ST and the HF 
subtypes was previously unexplored. Recently, a study by Pandey et al (12) demonstrated 
an inverse, dose-response relationship between leisure-time PA and risk of overall HF 
and HFpEF, but not HFrEF. The authors suggested that this association is likely due to 
the different potential mechanisms in which PA lowers cardiovascular risk and the 
difference in the pathophysiology of HFpEF and HFrEF. As lower amounts of ST, 
independent of PA, are also associated with lower cardiovascular risk (17), this rationale 
could also potentially explain the relationship between HFpEF and ST. 
 This study adds to the literature by characterizing, for the first time, the positive 
relationship between ST and risk of HFpEF, independent of intentional exercise and 
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adiposity. This study suggests that spending > 4.5 h/d sedentary, regardless of intentional 
exercise or adiposity, significantly increases risk of HFpEF. Reducing ST, along with 
increasing PA, should be emphasized to prevent the development of HFpEF and should 
be a therapeutic target to potentially prevent the pathological progression of HFpEF. 
Future studies should investigate ST objectively, and seek to establish a target goal for 
ST recommendations for this population.  
This study was not without limitations. The use of self-reported baseline ST is subject 
to recall and self-report bias. Additionally, ST was not objectively measured. The time to 
the first HF event was used to establish incident HF and EF, therefore subsequent HF 
events by the same participant or changes in EF measurement over time were not 
included in the analysis. Baseline ST and PA were examined for all participants, changes 
in behavior over the timeframe of the study were not taken into consideration for risk 
determination. Individuals without EF data at the time of the first HF event were not 
included in the analysis.  
In conclusion, ST is positively associated with the cumulative risk of HFpEF. 
This relationship is independent of demographics, traditional risk factors, intentional 
exercise, and adiposity measures. This identifies a potential area of intervention for 
preventing HFpEF and adds to the evidence of HFpEF and HFrEF having separate causal 
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